Azaya Therapeutics - Lipsomal Nanoparticle Technology's Unit Acquisition

Azaya Therapeutics - Lipsomal Nanoparticle Technology raised a round of funding on January 19, 2017. Investors include Cytori Therapeutics.

Azaya is a nanotherapy company utilizing a patented drug delivery technology platform. The tumor-targeted technology aims to allow the company to reformulate marketed chemotherapy drugs to increase th…

Articles about Azaya Therapeutics - Lipsomal Nanoparticle Technology's Unit Acquisition: